Patents by Inventor Armando PEREZ TORRES

Armando PEREZ TORRES has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of the GK-1 peptide as an antitumoral and/or antimetastatic agent
    Patent number: 11020449
    Abstract: The present invention refers to the use of the peptide defined by the amino acid sequence G-Y-Y-Y-P-S-D-P-N-T-F-Y-A-P-P-Y-S-A, named GK-1, to be used as an antitumor and antimetastatic agent or for the treatment of cancer, specifically of basal cell carcinoma, squamous cell carcinoma, transitional cell carcinoma, and adenocarcinoma, and preferably for the treatment of breast cancer.
    Type: Grant
    Filed: May 18, 2017
    Date of Patent: June 1, 2021
    Assignee: UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO
    Inventors: Edda Lydia Sciutto Conde, Gladis del Carmen Fragoso Gonzalez, Diana Torres Garcia, Jacquelynne Brenda Cervantes Torres, Rene Alvaro Segura Velazquez, Armando Perez Torres, Karen Manucharyan
  • USE OF THE GK-1 PEPTIDE AS AN ANTITUMORAL AND/OR ANTIMETASTATIC AGENT
    Publication number: 20200222495
    Abstract: The present invention refers to the use of the peptide defined by the amino acid sequence G-Y-Y-Y-P-S-D-P-N-T-F-Y-A-P-P-Y-S-A, named GK-1, to be used as an antitumor and antimetastatic agent or for the treatment of cancer, specifically of basal cell carcinoma, squamous cell carcinoma, transitional cell carcinoma, and adenocarcinoma, and preferably for the treatment of breast cancer.
    Type: Application
    Filed: May 18, 2017
    Publication date: July 16, 2020
    Inventors: Edda Lydia Sciutto Conde, Gladis del Carmen Fragoso Gonzalez, Diana Torres Garcia, Jacquelynne Brenda Cervantes Torres, Rene Alvaro Segura Velazquez, Armando Perez Torres, Karen Manucharyan
  • Nasal vaccine against the development of atherosclerosis disease and fatty liver
    Patent number: 9539312
    Abstract: The present invention provides a novel vaccine compound of micellar nanoparticles to be administered intranasally to treat and/or prevent the disease called atherosclerosis, which results from an abnormal metabolism of circulating lipids. The novelty of the vaccine compound of the present invention is the use of Archaebacterian lipids, lysophosphatidylcholine, and phosphatidylcholine, which give nanoparticles stability and facilitates antigen presentation in its appropriate secondary peptidic conformation. A novel process for the preparation of vaccine compounds which allows obtaining homogeneous nanoparticles with high stability is also presented in this invention.
    Type: Grant
    Filed: June 26, 2013
    Date of Patent: January 10, 2017
    Assignee: UNIVERSIDAD NACIONAL AUTONOMA DE MEXICO
    Inventors: Jaime Mas Oliva, Blanca Alicia Delgado Coello, Victor Guadalupe García Gonzalez, Armando Perez Torres
  • NASAL VACCINE AGAINST THE DEVELOPMENT OF ATHEROSCLEROSIS DISEASE AND FATTY LIVER
    Publication number: 20150328296
    Abstract: The present invention provides a novel vaccine compound of micellar nanoparticles to be administered intranasally to treat and/or prevent the disease called atherosclerosis, which results from an abnormal metabolism of circulating lipids. The novelty of the vaccine compound of the present invention is the use of Archaebacterian lipids, lysophosphatidylcholine, and phosphatidylcholine, which give nanoparticles stability and facilitates antigen presentation in its appropriate secondary peptidic conformation. A novel process for the preparation of vaccine compounds which allows obtaining homogeneous nanoparticles with high stability is also presented in this invention.
    Type: Application
    Filed: June 26, 2013
    Publication date: November 19, 2015
    Inventors: Jaime MAS OLIVA, Blanca Alicia DELGADO COELLO, Victor Guadalupe GARCIA GONZALEZ, Armando PEREZ TORRES